MKS (NASDAQ:MKSI) Price Target Raised to $260.00

MKS (NASDAQ:MKSI) had its price target lifted by Needham & Company LLC from $210.00 to $260.00 in a report published on Thursday, Marketbeat.com reports. Needham & Company LLC currently has a buy rating on the scientific and technical instruments company’s stock.

Several other equities analysts have also recently issued reports on the company. The Goldman Sachs Group increased their price objective on shares of MKS from $92.00 to $125.00 and gave the company a “sell” rating in a research note on Thursday, October 9th. Morgan Stanley reiterated an “overweight” rating and issued a $151.00 price target on shares of MKS in a research report on Monday, October 13th. Bank of America upped their target price on MKS from $200.00 to $215.00 and gave the company a “buy” rating in a research note on Tuesday, January 13th. Deutsche Bank Aktiengesellschaft set a $175.00 price target on MKS and gave the stock a “buy” rating in a research report on Friday, October 31st. Finally, Wall Street Zen downgraded MKS from a “strong-buy” rating to a “buy” rating in a research report on Saturday, January 3rd. Ten research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $227.75.

MKS Stock Performance

Shares of MKSI stock opened at $217.06 on Thursday. MKS has a 12 month low of $54.84 and a 12 month high of $233.11. The company has a current ratio of 2.86, a quick ratio of 1.81 and a debt-to-equity ratio of 1.64. The company has a market cap of $14.58 billion, a P/E ratio of 52.68, a PEG ratio of 1.99 and a beta of 1.92. The firm has a fifty day moving average price of $169.36 and a 200 day moving average price of $136.43.

MKS (NASDAQ:MKSI) last posted its earnings results on Wednesday, November 5th. The scientific and technical instruments company reported $1.93 EPS for the quarter, beating analysts’ consensus estimates of $1.80 by $0.13. MKS had a net margin of 7.25% and a return on equity of 20.80%. The firm had revenue of $988.00 million for the quarter, compared to the consensus estimate of $963.87 million. During the same period last year, the firm posted $1.72 EPS. The company’s revenue was up 10.3% on a year-over-year basis. MKS has set its Q4 2025 guidance at 1.930-2.610 EPS. Sell-side analysts predict that MKS will post 6.94 earnings per share for the current fiscal year.

MKS Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 5th. Investors of record on Monday, November 24th were given a dividend of $0.22 per share. This represents a $0.88 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend was Monday, November 24th. MKS’s dividend payout ratio is 21.36%.

Insider Buying and Selling

In other MKS news, Director Elizabeth Mora sold 300 shares of the stock in a transaction that occurred on Tuesday, December 2nd. The shares were sold at an average price of $158.81, for a total value of $47,643.00. Following the completion of the sale, the director owned 18,963 shares of the company’s stock, valued at $3,011,514.03. This trade represents a 1.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.57% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. raised its holdings in MKS by 4.0% in the third quarter. Vanguard Group Inc. now owns 7,752,097 shares of the scientific and technical instruments company’s stock valued at $959,477,000 after acquiring an additional 295,480 shares in the last quarter. Cooke & Bieler LP raised its stake in shares of MKS by 7.7% in the 3rd quarter. Cooke & Bieler LP now owns 1,321,877 shares of the scientific and technical instruments company’s stock valued at $163,609,000 after purchasing an additional 94,692 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of MKS by 30.8% during the third quarter. Dimensional Fund Advisors LP now owns 1,265,365 shares of the scientific and technical instruments company’s stock worth $156,602,000 after purchasing an additional 297,850 shares during the last quarter. Geode Capital Management LLC grew its stake in MKS by 2.9% in the second quarter. Geode Capital Management LLC now owns 1,258,108 shares of the scientific and technical instruments company’s stock worth $125,025,000 after purchasing an additional 35,065 shares in the last quarter. Finally, Channing Capital Management LLC increased its holdings in MKS by 79.3% in the second quarter. Channing Capital Management LLC now owns 991,298 shares of the scientific and technical instruments company’s stock valued at $98,495,000 after buying an additional 438,338 shares during the last quarter. Hedge funds and other institutional investors own 99.79% of the company’s stock.

MKS News Roundup

Here are the key news stories impacting MKS this week:

• Positive Sentiment: Several brokerages raised price targets, signaling stronger analyst conviction — TD Cowen bumped its target to $230. MKS Inc. price target raised to $230 from $200 at TD Cowen
• Positive Sentiment: Large upward revisions from other firms increased bullish interest (Needham to $260, Bank of America to $255, Morgan Stanley to $258, Cantor Fitzgerald to $300), suggesting analysts see meaningful upside vs. earlier levels. Analyst price target coverage (Benzinga)
• Positive Sentiment: MKS raised its Q4 guidance ahead of earnings (Needham also raised its target after the guidance update), which supports expectations for continued revenue/EPS strength. MKS increases Q4 guidance ahead of earnings; Needham hikes price target
• Positive Sentiment: Equity research pieces highlight MKS’s momentum and strong earnings-surprise track record, which can support further upside if the company sustains beat-and-raise results. Will MKS (MKSI) Beat Estimates Again?
• Neutral Sentiment: Not all upgrades are uniformly bullish: Wells Fargo raised its target to $210 but kept an “equal weight” rating, implying limited near-term upside from its view. Wells Fargo price target note
• Negative Sentiment: Analyst target dispersion and a premium valuation (market commentary points to a high P/E) create short-term volatility; despite bullish reports, these mixed signals likely contributed to profit-taking and the intraday pullback.

MKS Company Profile

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.